From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q1 2019 call → NOWe need to determine if management describes a recent crossing from candidate to approved/specified/listed/qualified status inside buyers' systems, such that future business can arrive without discrete selling events, and that this is new enough that most volume is still ahead. Scan the transcript for relevant statements. Key points: - Government Solutions segment: contracts like GTACS, orders for manpack terminals, etc. These are orders under existing contracts. But is there a description of being newly placed into a procurement system? - The troposcatter contract: "we received a $9.1 million contract to supply a foreign military customer" - that's a specific order. - The RFP for troposcatter equipment to replace DOD's Track 170 terminals: "we are still waiting for feedback from the U.S. government in response to a large multi-year RFP" - that's pending, not awarded. - BlueForce Tracking: "we demonstrated to the U.S. Army that our BFT-2 high capacity solution can provide for diversity or alternative communication pass" - demonstration, not yet a placement. - The MT-2025 transceivers: "we continue to work with them to deploy several thousand of our MT-25 satellite transceivers pursuant to an initial $11.7 million order" - that's an order, not a new status. - The $59 million contract award from U.S. Navy for SLM5650B satellite modem - that's a contract award, but is it a gateway? It's a specific contract with ceiling, but each order is still a delivery order under that contract. That's a typical contract vehicle, not a new "approved supplier" status that changes friction. The question asks about a phenomenon where the company has moved from candidate to default inside the routine pathway. Examples: being named to approved supplier list, written into specs, etc. In the transcript, management talks about being a participant in Northrop Grumman's program for the Navy's next generation Low Band program. That's a partnership, not a listing. The key is whether management conveys that the company has recently achieved a status that makes future business automatic without discrete selling. Look for phrases like "qualified," "listed," "approved," "specified," "preferred," etc. In the transcript, there is mention of "GTACS contract" - that's an existing contract vehicle. Not new.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.